Author Correction: PPP2R1A mutations portend improved survival after cancer immunotherapy
Yibo Dai(The University of Texas MD Anderson Cancer Center), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Jiakai Hou(Research Institute of Petroleum Exploration and Development), Ying Yuan(The University of Texas MD Anderson Cancer Center), Aaron Shafer(The University of Texas MD Anderson Cancer Center), Hao Nie(Tongji University), Shannon N. Westin(The University of Texas MD Anderson Cancer Center), Matthew Lastrapes(The University of Texas MD Anderson Cancer Center), Annalyn Welp(University of Virginia), Shrina Patel(The University of Texas MD Anderson Cancer Center), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center), Edwin R. Parra(The University of Texas MD Anderson Cancer Center), Pamela T. Soliman(The University of Texas MD Anderson Cancer Center), Emily Hinchcliff(The University of Texas MD Anderson Cancer Center), Linghua Wang(The University of Texas MD Anderson Cancer Center), Dhakshinamoorthy Ganeshan(The University of Texas MD Anderson Cancer Center), Anne Knisely(The University of Texas MD Anderson Cancer Center), Manoj Chelvanambi(The University of Texas MD Anderson Cancer Center), Joseph Celestino(The University of Texas MD Anderson Cancer Center), Renganayaki Pandurengan(The University of Texas MD Anderson Cancer Center), Minghao Dang(The University of Texas MD Anderson Cancer Center), Luis J. Montaner(The Wistar Institute), Weiyi Peng(University of Houston), Jinsong Liu(The University of Texas MD Anderson Cancer Center), R. Tyler Hillman(The University of Texas MD Anderson Cancer Center), Rugang Zhang(The University of Texas MD Anderson Cancer Center), Karen H. Lu(The University of Texas MD Anderson Cancer Center), Bryan Fellman(The University of Texas MD Anderson Cancer Center), Baohua Sun(The University of Texas MD Anderson Cancer Center), Sanghoon Lee(The University of Texas MD Anderson Cancer Center), Chen Wang(Hospital of Hebei Province), Heng Liu(The Wistar Institute), Zhe Yuan(The Wistar Institute), Stéphanie Jean, Anil K. Sood(The University of Texas MD Anderson Cancer Center), Ami Patel(The University of Texas MD Anderson Cancer Center), David M. Gershenson(The University of Texas MD Anderson Cancer Center), Larissa A. Meyer, Yan Liu(The University of Texas MD Anderson Cancer Center), Mitsutake Yano(The University of Texas MD Anderson Cancer Center)
Cited by 1
Related Papers
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
|Cell|2018|2k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k